Join
Live feed
·
INSIDERFilingvia Quantisnow
G1 Therapeutics Inc. logo

Malik Rajesh was granted 37,300 shares and sold $11,537 worth of shares (3,740 units at $3.08), increasing direct ownership by 25% to 169,938 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GTHX (G1 Therapeutics Inc.) and more on Quantisnow.